Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595862 · ClinicalTrials.gov registry record · NA
Open Pilot Trial Evaluating an Avatar-Guided Intervention for Emerging Adults With Alcohol Use Problems and Suicide Risk
A NA study of Suicidal Ideation and Binge Drinking, sponsored by University of Massachusetts, Worcester.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT06595862: Active NA study of Suicidal Ideation and Binge Drinking, sponsored by University of Massachusetts, Worcester.
NCT06595862 is a NA study of Suicidal Ideation and Binge Drinking that is active but no longer recruiting, run by University of Massachusetts, Worcester. The registered enrollment target is 10 participants, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06595862, a NA study of Suicidal Ideation and Binge Drinking, is active but no longer recruiting, sponsored by University of Massachusetts, Worcester.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is an open pilot usability trial to test the 1) usability of a newly developed mobile health intervention to help manage suicidal ideation and alcohol use problems and 2) feasibility of research protocols with emerging adults (18-29 year-olds) who present to the emergency department.
Primary Outcome
If any System Usability Items are less than 3.5 out of 5, those aspects of the digital intervention will be revised in the beta version.
Conditions Studied
Interventions
- BEHAVIORAL EA-Avatar
Study Locations (2)
Massachusetts
- UMass Memorial Health - Marlborough Hospital - Marlborough
- UMass Memorial, University Campus - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-01-31 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What the registry record for NCT06595862 still lists
NCT06595862 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 268-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which EA-Avatar is the first listed.
NCT06595862 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06595862 about?
NCT06595862 is a clinical study titled "Open Pilot Trial Evaluating an Avatar-Guided Intervention for Emerging Adults With Alcohol Use Problems and Suicide Risk". This study is an open pilot usability trial to test the 1) usability of a newly developed mobile health intervention to help manage suicidal ideation and alcohol use problems and 2) feasibility of research protocols with emerging adults (18-29 year-olds) who present to the emergency department.
What is the current status of trial NCT06595862?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-01-31. Estimated completion is 2026-05-31.
What conditions does trial NCT06595862 study?
This clinical trial studies the following conditions: Suicidal Ideation, Binge Drinking.
What interventions are being tested in trial NCT06595862?
The interventions under investigation include: EA-Avatar (BEHAVIORAL).
Who is sponsoring clinical trial NCT06595862?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06595862 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06595862's enrollment target sits among peer trials
10 83rd of 84 the lowest of 84 other Suicidal Ideation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Crisis Response Planning for Military Personnel
RECRUITING · NA
-
Suicide Intervention for Alaska Native Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI